drugset / Trial / NCT05523609
Vitamin D and Calcium Supplementation in Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims at assessing the vitamin Dstatus in breast cancer patients who receive letrozole for more than two months and to evaluate effects of vitamin D3 and calcium supplementation on arthalgia caused by letrozole on these patients.
Timeline
- Start
- 2022-11-01
- Primary completion
- 2024-09
- Completion
- 2024-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcium carbonate | Other / unclassified | 1000 mg | — |
| Subject | Cholecalciferol | Other / unclassified | 2000 iu | — |
| Background | Letrozole | Other / unclassified | 2.5 mg | — |